Skip to main content
ALLIANCE PHARMA PLC logo

ALLIANCE PHARMA PLC — Investor Relations & Filings

Ticker · APH ISIN · GB0031030819 LEI · 213800RYIWZA4Q5WPZ13 IL Wholesale and retail trade
Open in API
Filings indexed 492 across all filing types
Latest filing 2023-08-29 Major Shareholding Noti…
Country GB United Kingdom
Listing IL APH

About ALLIANCE PHARMA PLC

https://www.alliancepharmaceuticals.com/

Alliance Pharma PLC is an international specialty pharmaceutical company with a primary focus on consumer healthcare. The company's business model is centered on the acquisition, licensing, and marketing of a portfolio of consumer health products and prescription medicines. It operates globally, investing in its key brands to empower consumers to improve their health and wellbeing. A core part of its strategy is the ongoing development to become a high-performing consumer healthcare company.

Recent filings

Filing Released Lang Actions
Notification of Major Holdings
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled with 'RNS Number : 6689K' and contains the standard footer indicating it is provided by RNS, the news service of the London Stock Exchange, approved by the FCA. The content itself is a 'TR-1: Standard form for notification of major holdings' detailing a change in voting rights by a shareholder (Royal Bank of Canada PH/RBC Global Asset Management (UK) Limited). This type of mandatory regulatory disclosure, especially when originating from RNS, fits best under the general 'Regulatory Filings' category, as there is no specific code for 'Major Shareholding Notification' that aligns perfectly with the provided list (MRQ is defined as 'Major Shareholding Notification' but usually refers to a specific periodic filing, whereas TR-1 is a real-time disclosure). Given the RNS source and the nature of the filing (a mandatory regulatory disclosure not covered by more specific codes like DIRS or DIV), RNS is the most appropriate fallback.
2023-08-29 English
Notification of Major Holdings
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled with an 'RNS Number' and contains the header 'NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA...)' and references 'TR-1: Standard form'. This form is used to notify changes in major shareholdings, which directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the core content is a specific regulatory filing about share ownership changes, making MRQ the most precise classification over the general RNS fallback.
2023-08-15 English
Notification of Half Year Results
Report Publication Announcement Classification · 99% confidence The document is a short announcement (3993 characters) released via RNS (RNS Number : 8452I) from Alliance Pharma PLC. The title is "Notification of Half Year Results" and the text explicitly states that the interim results (which correspond to a comprehensive report for a period shorter than a year, like an IR) will be released on a future date (Tuesday 26 September 2023). Since this document is merely announcing the future publication date of the actual results and providing details for an analyst meeting, it fits the definition of a Report Publication Announcement (RPA) rather than the Interim Report (IR) itself. The presence of the RNS header and the short length strongly support the RPA classification based on the 'MENU VS MEAL' rule.
2023-08-10 English
Director Dealing
Director's Dealing Classification · 100% confidence The document is an official notification released via RNS (RNS Number : 6659G) on July 20, 2023. The content explicitly details a transaction ('Purchase of shares') made by a Person Discharging Managerial Responsibilities (PDMR), Jo LeCouilliard, the non-executive Chair. This type of filing, reporting personal share transactions by directors and executives, directly corresponds to the definition of 'Director's Dealing'. The specific code for this is DIRS.
2023-07-20 English
Director Dealings
Director's Dealing Classification · 100% confidence The document explicitly details transactions (purchases) of ordinary shares by the Chief Financial Officer (Andrew Franklin) and a Non-Executive Director (Richard Jones). This type of filing, reporting personal share transactions by persons discharging managerial responsibilities (PDMRs), directly corresponds to the definition of Director's Dealing. The presence of the RNS Number and the reference to EU Market Abuse Regulation further confirms it is a regulatory disclosure related to insider trading/director transactions. This matches the 'Director's Dealing' category (DIRS).
2023-07-19 English
Half Year Trading Update
Earnings Release Classification · 100% confidence The document is titled 'Half Year Trading Update' and provides financial performance summaries for the six months ended 30 June 2023. It discusses revenues (£82.4m), brand performance (Kelo-Cote, Nizoral, Amberen), cash flow, and debt, while explicitly stating that the full interim results are expected on 19 September 2023. This structure—a summary update for a period shorter than a year, preceding the full report—is characteristic of an Interim Report (IR). Although it contains trading update elements often seen in an Earnings Release (ER), the depth of financial metrics and the context of a 'Half Year' report strongly align it with the comprehensive nature of an Interim Report (IR) rather than just the initial highlights of an ER. H1 2023
2023-07-18 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.